Neurotrope, Inc.

Period: Jan 7, 2016 to Apr 28, 2017

Lead Plaintiff Deadline: Jul 17, 2017

Summary of Case:

A securities class action has been filed against Neurotrope, Inc. (NASDAQ:NTRP) on behalf beha1f of all persons who purchased or otherwise acquired Neurotrope common stock between January 7, 2016, and April 28, 2017.  This case has been filed in the USDC - NY Southern.

On February 10, 2017, Home Capital Group disclosed that it had received an enforcement notice from the Ontario Securities Commission ("OSC"). The notice indicated that OSC has reached the preliminary conclusion that Home Capital Group "failed to meet its continuous disclosure obligations" in 2014 and 2015. Then on April 19, 2017, the OSC alleged that CFO Robert Morton and two former CEOs of Home Capital, Gerald Soloway and Martin Reid, had unlawfully misled shareholders by waiting until after the May 2015 filing of its 2014 annual report and its first-quarter 2015 report to disclose the fraudulent activities performed by 45 of its brokers. Indeed, the OSC claims the Company was aware of these activities as early as February 10, 2015 and lied about the cause of the decline in lending.

If you purchased this company's shares during the Class Period and suffered a loss or for further information about the case, please review the links below.

Join This Action